-
effectivehealthcare.ahrq.gov/sites/default/files/mccormack-presentation.pdf
May 29, 2025 - McCormack-notes-151008 copy - Teresa
My talk today is about engaging patients with
low health
literacy.
1
Health literacy is a key factor in securing access to healthcare services. So in my talk
today, I’ll talk a little bit about health literacy and what it is, how we measure health
literacy and the sta…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
May 01, 2013 - determine
the effect of multicomponent interventions on
ED visits/ hospitalizations due to high rates of
participant
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - The participant then picks up a free naloxone kit at a predetermined
Project Lazarus pharmacy.3
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - This is an example of a choice set, which is used in
conjoint analysis, so we offer each participant … stakeholders seems to
include only those who are professionally involved and not
people with COPD and the participant … We did get a question from a participant
can you randomize stakeholders to a subset of pair-wise
comparisons
-
effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
May 29, 2025 - Using Collaborative Platforms for Communities of Practice
INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE
SPEAKER: LAKSHMI GRAMA,
SENIOR DIGITAL CONTENT STRATEGIST,
NATIONAL CANCER INSTITUTE (NCI)
GRAMA: I’m Lakshmi Grama from the Office of Communications and
Education at the National …
-
effectivehealthcare.ahrq.gov/sites/default/files/lessons-presentation.pdf
January 01, 2013 - Community-Based Participatory Research Slides Text Version
Community-Based Participat…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
February 01, 2014 - Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention
Methods Research Report
Evaluation of the Benefits and Harms of Aspirin for
Primary Prevention of Cardiovascular Events: A
Comparison of Quantitative Approaches
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_executive.pdf
January 01, 2010 - These studies used
women unfamiliar to the study participant who had
experience and training in childbirth
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
December 23, 2023 - Adverse Events Associated with COVID-19 Pharmaceutical Treatments
Evidence-based Practice Center Rapid Review Protocol
Project Title: Adverse Events Associated with COVID-19 Pharmaceutical
Treatments
I. Background and Objectives for the Systematic Review
The Public Readiness and Emergency Preparedness A…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - List of Evidence Tables
Category Evidence Table
Included systematic reviews Evidence Table C-1. Characteristics and outcomes of included systematic reviews.
Included primary studies Evidence Table C-2. Characteristics and outcomes of primary studies looking at staff-level initiative interventions.
Evidence Table C…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - Cover Page
An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing
Surveillance
Amar Gupta
Eller College of Management
The University of Arizona
gupta@eller.arizona.edu
Ray Woosley
The Critical Path Institute
4280 N. Campbell Ave. #214
Tucson, AZ 85718
Rwo…
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - Cover Page
An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing
Surveillance
Amar Gupta
Eller College of Management
The University of Arizona
gupta@eller.arizona.edu
Ray Woosley
The Critical Path Institute
4280 N. Campbell Ave. #214
Tucson, AZ 85718
Rwo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
May 14, 2025 - prediction and 97 percent for the primary or
secondary prediction; however, authors
excluding one participant … For me, the outcome is what can
occur at the level of an individual participant
(e.g. a cancer death … Notably, there were no adverse
events reported related to any diagnostic
procedures in any participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
December 31, 2022 - remained unvaccinated had detectable anti-S IgG approximately 13 months later (range 387–401
days; 1 participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
February 01, 2014 - Characteristics
on Effectiveness
In total, studies from 18 populations provide information
about how participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
July 10, 2018 - Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder
Source: https://effectivehealthcare.ahrq.gov/
Published on-line: July 10, 2018
Evidence-based Practice Center Program Technical Brief Protocol
Project Title: Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder
Source: https://effectivehealthcare.ahrq.gov/
Published on-line: July 10, 2018
Evidence-based Practice Center Program Technical Brief Protocol
Project Title: Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress
…
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_bonoff.pdf
January 01, 2000 - Slide 1
Presented By: Amy Bonoff
Training and Support for
Patients and Consumers
Engaged in Research
Training & Support
• Training and continued learning opportunities
are a key element for success
• Methods to support patient and consumer
involvement are evolving
– NBCC Project LEAD
– FDA Patie…
-
effectivehealthcare.ahrq.gov/sites/default/files/bonoff-text.pdf
January 01, 2000 - Training and Support for Patients and Consumers Engaged in Research
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
August 07, 2018 - which assume that the
censoring of participants is
noninformative, that is, that the
reason for the participant … offer for enhancing
retention in clinical trials – “multiple secondary contacts who do not
live with participant